Sensus Healthcare, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27.5M | $41.8M | $24.4M | $44.5M | $27.0M | $9.6M | $27.3M | $26.4M |
| Cost of Revenue | $15.6M | $17.4M | $10.3M | $14.9M | $10.1M | $4.3M | $9.7M | $9.5M |
| Gross Profit | $11.9M | $24.4M | $14.1M | $29.6M | $17.0M | $5.2M | $17.6M | $16.9M |
| Gross Margin | 43.2% | 58.4% | 57.6% | 66.5% | 62.8% | 54.8% | 64.4% | 64.0% |
| Operating Expenses | ||||||||
| Research & Development | $7.8M | $4.2M | $3.7M | $3.5M | $3.4M | $4.2M | $6.4M | $6.3M |
| SG&A Expense | $7.9M | $7.1M | $5.2M | $5.0M | $4.6M | $4.0M | $4.0M | $4.1M |
| Operating Income | $-10.3M | $8.1M | $-382.0K | $14.8M | $4.1M | $-8.2M | $-2.0M | $-2.0M |
| Operating Margin | -37.5% | 19.4% | -1.6% | 33.3% | 15.2% | -86.0% | -7.2% | -7.6% |
| Interest Expense | — | $-932.0K | $-992.0K | $-380.0K | $2.0K | $14.0K | — | $156.7K |
| Pretax Income | $-9.6M | $9.0M | $652.0K | $28.0M | $4.1M | — | — | — |
| Income Tax Expense | $-1.9M | $2.4M | $167.0K | $3.7M | — | — | — | — |
| Net Income | $-7.7M | $6.6M | $485.0K | $24.2M | $4.1M | $-6.8M | $-1.7M | $-2.0M |
| Net Margin | -28.1% | 15.9% | 2.0% | 54.4% | 15.2% | -71.4% | -6.2% | -7.7% |
| EPS (Basic) | $-0.47 | $0.41 | $0.03 | $1.47 | $0.25 | $-0.42 | $-0.10 | $-0.14 |
| EPS (Diluted) | $-0.47 | $0.41 | $0.03 | $1.46 | $0.25 | $-0.42 | $-0.10 | $-0.14 |
| Shares Outstanding (Basic) | 16.3M | 16.3M | 16.3M | 16.5M | 16.5M | 16.4M | 16.5M | 16.1M |
| Shares Outstanding (Diluted) | 16.3M | 16.4M | 16.3M | 16.6M | 16.5M | 16.4M | 16.5M | 16.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |